Suppr超能文献

抗生素治疗对产 KPC 肺炎克雷伯菌在小鼠肠道定植和消除的影响。

Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.

机构信息

Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.

出版信息

Antimicrob Agents Chemother. 2011 Jun;55(6):2585-9. doi: 10.1128/AAC.00891-10. Epub 2011 Mar 21.

Abstract

An understanding of the impact of antibiotics on the intestinal reservoir of KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is important to prevent its emergence. We used a mouse model to examine the effect of antibiotic treatment on the establishment and elimination of intestinal colonization with KPC-Kp. Mice (10 per group) received subcutaneous antibiotics daily for 8 days. On day 3 of treatment, 10(3) CFU of KPC-Kp was given orogastrically, and concentrations of KPC-Kp in stool were monitored. Additional experiments assessed the effects of antibiotic treatment on concentrations of total anaerobes and Bacteroides spp. in stool and the efficacy of orogastric gentamicin and polymyxin E in suppressing KPC-Kp colonization. Of four antibiotics with minimal activity against the KPC-Kp test strain (MIC ≥ 16 μg/ml), those that suppressed total anaerobes and bacteroides (i.e., clindamycin and piperacillin-tazobactam) promoted colonization by KPC-Kp (P < 0.001), whereas agents that did not suppress total anaerobes or bacteroides (i.e., ciprofloxacin and cefepime) did not (P = 0.35). Of two agents with moderate activity against the KPC-Kp test strain, ertapenem (MIC, 4 μg/ml) did not promote colonization by KPC-Kp, whereas tigecycline (MIC, 3 μg/ml) did (P < 0.001), despite not reducing levels of total anaerobes or bacteroides. Orogastric treatment with gentamicin and polymyxin E suppressed KPC-Kp to undetectable levels in the majority of mice. These data suggest that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against KPC-Kp promote colonization by this organism. The administration of nonabsorbed oral antibiotics may be an effective strategy to suppress colonization with KPC-Kp.

摘要

了解抗生素对产 KPC 碳青霉烯酶肺炎克雷伯菌 (KPC-Kp) 肠道储库的影响对于预防其出现很重要。我们使用小鼠模型研究了抗生素治疗对肠道定植 KPC-Kp 的建立和消除的影响。每组 10 只小鼠每天接受皮下抗生素治疗 8 天。在治疗第 3 天,经口给予 10(3) CFU 的 KPC-Kp,并监测粪便中 KPC-Kp 的浓度。其他实验评估了抗生素治疗对粪便中总厌氧菌和拟杆菌属浓度的影响,以及经口给予庆大霉素和多粘菌素 E 抑制 KPC-Kp 定植的效果。在对 KPC-Kp 测试菌株活性最小的四种抗生素(MIC≥16μg/ml)中,抑制总厌氧菌和拟杆菌的药物(即克林霉素和哌拉西林-他唑巴坦)促进了 KPC-Kp 的定植(P<0.001),而不抑制总厌氧菌或拟杆菌的药物(即环丙沙星和头孢吡肟)则没有(P=0.35)。在对 KPC-Kp 测试菌株具有中度活性的两种药物中,厄他培南(MIC,4μg/ml)未促进 KPC-Kp 的定植,而替加环素(MIC,3μg/ml)则促进了 KPC-Kp 的定植(P<0.001),尽管它没有降低总厌氧菌或拟杆菌的水平。经口给予庆大霉素和多粘菌素 E 可使大多数小鼠粪便中的 KPC-Kp 抑制到无法检测的水平。这些数据表明,扰乱肠道厌氧菌群且对 KPC-Kp 缺乏显著活性的抗生素可促进该生物体的定植。给予非吸收性口服抗生素可能是抑制 KPC-Kp 定植的有效策略。

相似文献

1
Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.
Antimicrob Agents Chemother. 2011 Jun;55(6):2585-9. doi: 10.1128/AAC.00891-10. Epub 2011 Mar 21.
6
Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Int J Antimicrob Agents. 2018 Jul;52(1):114-118. doi: 10.1016/j.ijantimicag.2018.02.010. Epub 2018 Feb 24.
7
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.
J Antimicrob Chemother. 2009 Nov;64(5):1102-10. doi: 10.1093/jac/dkp327. Epub 2009 Sep 9.
8
KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
J Glob Antimicrob Resist. 2018 Dec;15:173-177. doi: 10.1016/j.jgar.2018.07.011. Epub 2018 Jul 30.

引用本文的文献

4
A new model of intestinal colonization using larvae: testing hyperepidemic ESBL- and carbapenemase-producing clones.
Front Microbiol. 2024 Apr 10;15:1381051. doi: 10.3389/fmicb.2024.1381051. eCollection 2024.
5
Deciphering the gastrointestinal carriage of .
Infect Immun. 2024 Sep 10;92(9):e0048223. doi: 10.1128/iai.00482-23. Epub 2024 Apr 10.
6
Animal models of mucosal infections.
Front Microbiol. 2024 Mar 15;15:1367422. doi: 10.3389/fmicb.2024.1367422. eCollection 2024.
7
Antibiotics in anesthesia and critical care.
Ann Transl Med. 2024 Feb 1;12(1):6. doi: 10.21037/atm-22-5585. Epub 2023 Dec 13.
8
The impact of three carbapenems at a single-day dose on intestinal colonization resistance against carbapenem-resistant .
mSphere. 2023 Dec 20;8(6):e0047923. doi: 10.1128/msphere.00479-23. Epub 2023 Nov 27.

本文引用的文献

1
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
J Antimicrob Chemother. 2010 Jun;65(6):1119-25. doi: 10.1093/jac/dkq108. Epub 2010 Apr 8.
2
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5. doi: 10.1086/648451.
3
In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases.
Antimicrob Agents Chemother. 2009 Aug;53(8):3599-601. doi: 10.1128/AAC.00641-09. Epub 2009 Jun 15.
5
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.
Lancet Infect Dis. 2009 Apr;9(4):228-36. doi: 10.1016/S1473-3099(09)70054-4.
7
Decontamination of the digestive tract and oropharynx in ICU patients.
N Engl J Med. 2009 Jan 1;360(1):20-31. doi: 10.1056/NEJMoa0800394.
8
Carbapenem-resistant Enterobacteriaceae: a potential threat.
JAMA. 2008 Dec 24;300(24):2911-3. doi: 10.1001/jama.2008.896.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验